Edition:
United States

Orexigen Therapeutics Inc (OREX.OQ)

OREX.OQ on NASDAQ Stock Exchange Global Select Market

1.26USD
3:59pm EST
Change (% chg)

$-0.04 (-3.08%)
Prev Close
$1.30
Open
$1.30
Day's High
$1.30
Day's Low
$1.26
Volume
75,656
Avg. Vol
30,367
52-wk High
$5.69
52-wk Low
$1.26

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -2.06 December 13 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 1 1 1 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 3.00 3.00 3.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1 25.00 25.00 25.00 15.30
Quarter Ending Mar-18 1 27.50 27.50 27.50 --
Year Ending Dec-17 2 85.85 87.00 84.70 69.49
Year Ending Dec-18 2 133.25 156.50 110.00 --
Earnings (per share)
Quarter Ending Dec-17 1 -2.06 -2.06 -2.06 --
Quarter Ending Mar-18 1 -2.17 -2.17 -2.17 --
Year Ending Dec-17 2 -8.60 -7.13 -10.08 -5.02
Year Ending Dec-18 2 -5.15 -3.54 -6.76 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 24.20 18.90 5.30 21.89
Quarter Ending Jun-17 20.00 23.36 3.36 16.78
Quarter Ending Mar-17 20.00 19.15 0.85 4.27
Quarter Ending Dec-16 13.95 13.81 0.14 1.03
Quarter Ending Sep-16 8.17 7.00 1.17 14.29
Earnings (per share)
Quarter Ending Sep-17 -2.13 -1.35 0.78 -36.62
Quarter Ending Dec-16 -1.18 -3.20 2.02 -171.19
Quarter Ending Sep-16 -2.24 -2.06 0.18 -8.17
Quarter Ending Jun-16 -1.47 -2.53 1.06 -72.70
Quarter Ending Mar-16 -1.70 -1.50 0.20 -11.76

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 25.00 25.00 25.20 25.20 15.30
Quarter Ending Mar-18 27.50 27.50 27.50 27.50 --
Year Ending Dec-17 85.85 85.85 93.00 93.00 69.49
Year Ending Dec-18 133.25 133.25 135.15 135.15 --
Earnings (per share)
Quarter Ending Dec-17 -2.06 -2.06 -1.96 -1.96 --
Quarter Ending Mar-18 -2.17 -2.17 -2.07 -2.07 --
Year Ending Dec-17 -8.60 -8.60 -9.36 -9.36 -5.02
Year Ending Dec-18 -5.15 -6.76 -5.59 -5.59 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 1
Quarter Ending Mar-18 0 0 0 0
Year Ending Dec-17 0 0 0 2
Year Ending Dec-18 0 0 0 1
Earnings
Quarter Ending Dec-17 0 0 0 1
Quarter Ending Mar-18 0 0 0 1
Year Ending Dec-17 0 0 2 0
Year Ending Dec-18 0 0 1 1